"Collagen Type VII" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-fibrillar collagen involved in anchoring the epidermal BASEMENT MEMBRANE to underlying tissue. It is a homotrimer comprised of C-terminal and N-terminal globular domains connected by a central triple-helical region.
| Descriptor ID |
D024143
|
| MeSH Number(s) |
D12.776.860.300.250.400.300
|
| Concept/Terms |
Procollagen Type VII- Procollagen Type VII
- Type VII, Procollagen
- Type VII Procollagen
- Procollagen, Type VII
|
Below are MeSH descriptors whose meaning is more general than "Collagen Type VII".
Below are MeSH descriptors whose meaning is more specific than "Collagen Type VII".
This graph shows the total number of publications written about "Collagen Type VII" by people in this website by year, and whether "Collagen Type VII" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Collagen Type VII" by people in Profiles.
-
Protecting human amnion and chorion matrices during processing: Performance enhancement in a diabetic mouse model and human co-culture system. Wound Repair Regen. 2023 Jul-Aug; 31(4):475-488.
-
Identification of novel enriched recurrent chimeric COL7A1-UCN2 in human laryngeal cancer samples using deep sequencing. BMC Cancer. 2018 03 02; 18(1):248.
-
Sequence variants in nine different genes underlying rare skin disorders in 10 consanguineous families. Int J Dermatol. 2017 Dec; 56(12):1406-1413.
-
Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice. J Invest Dermatol. 2015 Dec; 135(12):3060-3067.
-
Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa. Mol Ther. 2014 Oct; 22(10):1741-52.
-
De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2014 Apr; 134(4):1138-1140.
-
Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure. Mol Ther. 2013 07; 21(7):1335-44.
-
Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol. 2013 Jul; 133(7):1910-3.
-
Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther. 2009 Jan; 17(1):26-33.
-
Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet. 2002 Dec; 32(4):670-5.